Workflow
Taysha wins FDA breakthrough tag for lead drug (TSHA:NASDAQ)

Taysha Gene Therapies (NASDAQ:TSHA) jumped ~39% on Thursday after the U.S. FDA granted its Breakthrough Therapy designation for the company's lead candidate TSHA-102 as a treatment for Rett syndrome, a rare neurodevelopmental disorder. Additionally, the gene therapy developer stated that the ...